Systemic Allergic Disorders: IgE-Mediated Disorders, Angioedema, Nonsteroidal Anti Inflammatory Drug Sensitivity and Stevens-Johnson Syndrome

[1]  A. Kaplan,et al.  Continuing Medical EducationAngioedema , 2005 .

[2]  T. Casale,et al.  Incidence and characteristics of angioedema associated with enalapril. , 2005, Archives of internal medicine.

[3]  S. Leu,et al.  Role of intradermal skin tests in the evaluation of clinically relevant respiratory allergy assessed using patient history and nasal challenges. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[5]  R. Wolf,et al.  Life-threatening acute adverse cutaneous drug reactions. , 2005, Clinics in dermatology.

[6]  R. Simon,et al.  Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) , 2003, Clinical reviews in allergy & immunology.

[7]  D. Stevenson,et al.  Pathogenesis of aspirin-exacerbated respiratory disease , 2003, Clinical reviews in allergy & immunology.

[8]  L. Naldi,et al.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.

[9]  M. Malice,et al.  Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[11]  A. Szczeklik,et al.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. , 2000, The European respiratory journal.

[12]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[13]  J. Roujeau,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? , 2000, Archives of dermatology.

[14]  B. Dahlén,et al.  Treatment of aspirin-intolerant asthma with antileukotrienes. , 2000, American journal of respiratory and critical care medicine.

[15]  H. Nelson.  Mechanisms of intranasal steroids in the management of upper respiratory allergic diseases. , 1999, The Journal of allergy and clinical immunology.

[16]  S. Durham,et al.  Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.

[17]  C. Zwillich,et al.  Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. , 1998, The Journal of allergy and clinical immunology.

[18]  N. Brown,et al.  Recurrent angiotensin-converting enzyme inhibitor-associated angioedema , 1997 .

[19]  B. Woodson,et al.  Surgical Treatment of Aspirin Triad Sinusitis , 1997, American journal of rhinology.

[20]  D. Strachan.  Epidemiology of hay fever: towards a community diagnosis , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  J. L. Scott,et al.  Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. , 1993, The American journal of emergency medicine.

[22]  O. Correia,et al.  Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. , 1993, Archives of dermatology.

[23]  M. Greaves,et al.  Angioedema: manifestations and management. , 1991, Journal of the American Academy of Dermatology.

[24]  T. Berger,et al.  Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. , 1991, Archives of dermatology.

[25]  M. Higgins,et al.  Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. 3. Second survey of the community. , 1974, The Journal of allergy and clinical immunology.

[26]  A. Stevens,et al.  A NEW ERUPTIVE FEVER ASSOCIATED WITH STOMATITIS AND OPHTHALMIA: REPORT OF TWO CASES IN CHILDREN , 1922 .

[27]  R. Simon,et al.  Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. , 2003, The Journal of allergy and clinical immunology.

[28]  J. Roujeau,et al.  Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. , 2003, Archives of dermatology.

[29]  A. Romano,et al.  Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. , 2002, The Journal of allergy and clinical immunology.

[30]  R. Stern,et al.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. , 1993, Archives of dermatology.